Fig. 1S
1 H NMR spectrum of kuguacin II (1).
Fig. 4S HMBC spectrum of kuguacin II (1).

Fig. 5S
1 H-1 H COSY spectrum of kuguacin II (1).
Fig. 6S
ROESY spectrum of kuguacin II (1).
Fig. 7S
1 H NMR spectrum of kuguacin III (2).
Fig. 8S
13 C NMR spectrum of kuguacin III (2).
Fig. 9S HSQC spectrum of kuguacin III (2).
Fig. 10S HMBC spectrum of kuguacin III (2).
Fig. 11S
1 H-1 H COSY spectrum of kuguacin III (2).
Fig. 12S ROESY spectrum of kuguacin III (2).
Fig. 13S
1 H NMR spectrum of kuguacin IV (3).
Fig. 14S
13 C NMR spectrum of kuguacin IV (3).
Fig. 15S HSQC spectrum of kuguacin IV (3).
Fig. 16S HMBC spectrum of kuguacin IV (3).
Fig. 17S
1 H-1 H COSY spectrum of kuguacin IV (3).
Fig. 18S ROESY spectrum of kuguacin IV (3).
Fig. 19S
1 H NMR spectrum of kuguacin V (4).
Fig. 20S
13 C NMR spectrum of kuguacin V (4).
Fig. 21S
HSQC spectrum of kuguacin V (4).
Fig. 22S
HMBC spectrum of kuguacin V (4).
Fig. 23S
1 H-1 H COSY spectrum of kuguacin V (4).
Fig. 24S
ROESY spectrum of kuguacin V (4).
Fig. 25S
1 H NMR spectrum of kuguacin VI (5).
Fig. 26S
13 C NMR spectrum of kuguacin VI (5). 
General experimental procedures
Melting points were obtained on an X-4 digital display micromelting point apparatus and were uncorrected. Optical rotations were carried out on a Perkin-Elmer model 241 polarimeter.
UV spectra were measured on a Shimadzu double-beam 210A spectrophotometer. The IR spectra were recorded on a Bio-Rad FTS-135 spectrometer with KBr pellets. 1 H, 13 C, and 2D
NMR spectra were recorded on Bruker DRX-500 or AV-600 instruments, with TMS as the internal standard. ESIMS, HRESIMS, and HREIMS data were acquired on an APIQSTAR time-of-flight mass spectrometer and a VG Autospec-3000 mass spectrometer, respectively. Merck, Darmstadt, Germany). Fractions were monitored by TLC, and spots were visualized by heating silica gel plates after spraying with aqueous 15% H 2 SO 4 . The insulin from bovine pancreas was purchased from Sigma-Aldrich (St. Louis, MO, USA), and its purity was ≥ 27 USP units per mg.
Glucose production assay
An amount of 1.2 × 10 7 cells/dish was seeded in 90-mm dishes. After two days, the cells were incubated in 5 mL of medium containing 500 nM of DEX and 0.1 mM of 8-(4-chlorophenylthio)adenosine 3,5-cyclic monophosphate sodium salt (pCPT-cAMP). In the treatment groups, the compounds (100 µg/mL) were added to the DEX/pCPT-cAMP supplemented media with herbal extracts. Insulin (10 nM) was added to the cells as a positive control. After 5 h incubation, media were removed and the cells were washed three times with PBS. Then, 2 mL of glucose production buffer, containing 5 mM sodium pyruvate and 50 mM sodium lactate in DMEM (without glucose and phenol red), were added and incubated with the cells for 3 h. The glucose concentration in the glucose production buffer was determined by an enzymatic-spectrophotometric glucose oxidase/peroxidase assay kit with modifications.
Briefly, 1 mL of glucose production buffer was mixed with 0.3 mL of glucose assay solution at 37°C for 5 min. Absorbance at 500 nm was recorded. The protein concentration of each sample was determined by the BCA assay. Cells were washed with PBS and lysed by 5 mL of 0.5 M of NaOH for 10 min. The lysate was neutralized with 5 mL of 0.5 M of HCl. The amount of glucose production was normalized by the protein concentration. The results are expressed as the percentage of glucose production of the negative control, which was the glucose production from the cells without treatment.
PEPCK activity assay
H4IIE cells were seeded in 90-mm dishes and treated as described in the glucose production assay until after 5 h incubation with DEX/pCPT-cAMP supplemented media, with or without sample treatment. After incubation, media were removed and cells were washed with PBS twice. Then, 200 µL of lysis buffer containing 20 mM Tris-HCl, 50 mM potassium chloride (KCl), 5 mM magnesium chloride (MgCl 2 ), 2 mM EDTA, 1 mM dithiothreitol (DTT), and 1%
polyethylene glycol with the pH adjusted to 6.6, were added to each dish. Cells were scrapped off, lysed with sonication, and centrifuged at 15000 × g for 5 min. Cell pellets were discarded, and 50 µl of supernatant were mixed with 500 µl of PEPCK assay buffer containing 110 mM imidazole-HCl, 45 mM NaHCO 3 , 2 mM phosphoenolpyruvate, 3 mM MgSO 4 , 3 mM manganese chloride (MnCl 2 ), 13 mM sodium fluoride (NaF), 1 mM DTT, 0.5 mM GDP, 0.15 mM NADH, and 6 units malate dehydrogenase with the pH adjusted to 6.8 for measuring the PEPCK activity. Absorbance of the mixture was monitored at 340 nm for 1 min at 15 s intervals. The rate of absorbance change was recorded. Protein content of the supernatant was determined by the BCA assay. Absorbance change was normalized by the protein content.
PEPCK activity of each sample is expressed as the percentage of negative control, which was the PEPCK activity from the cells without sample treatment. The total number of independent reflections measured was 6108 of which 2432 were observed (|F| 2  2|F| 2 ). Final indices: R 1 = 0.0776, wR 2 = 0.1610. The crystal structure of compound 1 was solved by the direct method SHELXS-97 and expanded using difference 
X-ray crystallographic analysis
